Christopher G. Rowan PhD (Chris) is the Founder and President of Veritas Research Foundation (501(c)(3)) and Adjunct Associate Professor at Rutgers University Center for Pharmacoepidemiology and Treatment Sciences Center (PETS). He is a pharmacoepidemiologist, biostatistician, and drug safety researcher by training. He has extensive experience using comparative methods to estimate causal relationships between medication exposure and adverse drug events (ADEs). His research vision is to safeguard public health using innovative strategies to detect, quantify, and verify drug related harm.
Chris is experienced designing and executing retrospective, observational drug safety studies using electronic health record (EHR) and health insurance claims databases – in a variety of disease and therapeutic areas. His recent publications include comparative safety/effectiveness research, predictive modeling studies, and methodologic investigations. His research proficiencies include study design, statistical programming analysis, interpretation of research findings, and dissemination through peer reviewed publications (abstracts and manuscripts) and presentation. Chris has a strong publication track-record and several ongoing collaborations with industry partners, academic researchers, and non-profit organizations.
Chris received his Doctor of Philosophy in Epidemiology with a minor in Biostatistics (specialty in pharmacoepidemiology) from the University of Pennsylvania. He received the Saul Winegrad award for outstanding dissertation. Chris conducted a pre-doctoral fellowship at the FDA in the Division of Drug Risk Evaluation. He is an active member of the International Society of Pharmacoepidemiology (ISPE) and serves as a regular reviewer for Pharmacoepidemiology and Drug Safety (PDS) and other prominent medical journals.